166 related articles for article (PubMed ID: 34229733)
41. Overall survival of Brazilian acute myeloid leukemia patients according to the European LeukemiaNet prognostic scoring system: a cross-sectional study.
Datoguia TS; Velloso EDRP; Helman R; Musacchio JG; Salvino MA; Soares RA; Higashi M; Fadel AV; E Silva RSA; Hamerschlak N; Santos FPS; Campregher PV
Med Oncol; 2018 Sep; 35(11):141. PubMed ID: 30187210
[TBL] [Abstract][Full Text] [Related]
42. A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia.
Herold T; Jurinovic V; Batcha AMN; Bamopoulos SA; Rothenberg-Thurley M; Ksienzyk B; Hartmann L; Greif PA; Phillippou-Massier J; Krebs S; Blum H; Amler S; Schneider S; Konstandin N; Sauerland MC; Görlich D; Berdel WE; Wörmann BJ; Tischer J; Subklewe M; Bohlander SK; Braess J; Hiddemann W; Metzeler KH; Mansmann U; Spiekermann K
Haematologica; 2018 Mar; 103(3):456-465. PubMed ID: 29242298
[TBL] [Abstract][Full Text] [Related]
43. Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukaemia undergoing allogeneic stem cell transplantation.
Hemmati PG; Vuong LG; Terwey TH; Jehn CF; le Coutre P; Penack O; Na IK; Dörken B; Arnold R
Eur J Haematol; 2017 Feb; 98(2):160-168. PubMed ID: 27706846
[TBL] [Abstract][Full Text] [Related]
44. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
45. Next-generation sequencing reveals gene mutations landscape and clonal evolution in patients with acute myeloid leukemia.
Chen X; Zhu H; Qiao C; Zhao S; Liu L; Wang Y; Jin H; Qian S; Wu Y
Hematology; 2021 Dec; 26(1):111-122. PubMed ID: 33491606
[TBL] [Abstract][Full Text] [Related]
46. Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype.
Zidan MA; Kamal Shaaban HM; Elghannam DM
Hematology; 2014 Jul; 19(5):267-74. PubMed ID: 24074521
[TBL] [Abstract][Full Text] [Related]
47. Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.
Lachowiez CA; Long N; Saultz J; Gandhi A; Newell LF; Hayes-Lattin B; Maziarz RT; Leonard J; Bottomly D; McWeeney S; Dunlap J; Press R; Meyers G; Swords R; Cook RJ; Tyner JW; Druker BJ; Traer E
Blood Adv; 2023 May; 7(9):1899-1909. PubMed ID: 36441905
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience.
Benicio MTL; Ribeiro AFT; Américo AD; Furtado FM; Glória AB; Lima AS; Santos SM; Xavier SG; Lucena-Araujo AR; Fagundes EM; Rego EM
Leuk Res; 2017 Sep; 60():109-114. PubMed ID: 28777950
[TBL] [Abstract][Full Text] [Related]
49. Predictive and Prognostic Markers in Adults With Acute Myeloid Leukemia: A Single-Institution Experience.
Gbadamosi B; Ezekwudo D; Bastola S; Jaiyesimi I
Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):e287-e294. PubMed ID: 29803615
[TBL] [Abstract][Full Text] [Related]
50. Cytogenetics in the management of acute myeloid leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Luquet I; Bidet A; Cuccuini W; Lafage-Pochitaloff M; Mozziconacci MJ; Terré C
Ann Biol Clin (Paris); 2016 Oct; 74(5):535-546. PubMed ID: 27545007
[TBL] [Abstract][Full Text] [Related]
51. Albumin-to-fibrinogen ratio is an independent prognostic parameter in de novo non-M3 acute myeloid leukemia.
Ding Y; Qi X; Li Y; Sun Y; Wan J; Luo C; Huang Y; Li Q; Wu G; Zhu X; Xu S
Clin Exp Med; 2023 Dec; 23(8):4597-4608. PubMed ID: 37914966
[TBL] [Abstract][Full Text] [Related]
52. Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting.
Attardi E; Savi A; Borsellino B; Piciocchi A; Cipriani M; Ottone T; Fabiani E; Divona M; Travaglini S; Pascale MR; Awada H; Durmaz A; Visconte V; Della Porta MG; Venditti A; Maciejewski JP; Gurnari C; Voso MT
Blood Adv; 2023 Sep; 7(17):5122-5131. PubMed ID: 37327116
[TBL] [Abstract][Full Text] [Related]
53. European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol.
Bataller A; Garrido A; Guijarro F; Oñate G; Diaz-Beyá M; Arnan M; Tormo M; Vives S; de Llano MPQ; Coll R; Gallardo D; Vall-Llovera F; Escoda L; Garcia-Guiñon A; Salamero O; Sampol A; Merchan BM; Bargay J; Castaño-Díez S; Esteban D; Oliver-Caldés A; Rivero A; Mozas P; López-Guerra M; Pratcorona M; Zamora L; Costa D; Rozman M; Nomdedéu JF; Colomer D; Brunet S; Sierra J; Esteve J
Blood Adv; 2022 Feb; 6(4):1193-1206. PubMed ID: 34911079
[TBL] [Abstract][Full Text] [Related]
54. Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG).
Gaidzik VI; Schlenk RF; Paschka P; Stölzle A; Späth D; Kuendgen A; von Lilienfeld-Toal M; Brugger W; Derigs HG; Kremers S; Greil R; Raghavachar A; Ringhoffer M; Salih HR; Wattad M; Kirchen HG; Runde V; Heil G; Petzer AL; Girschikofsky M; Heuser M; Kayser S; Goehring G; Teleanu MV; Schlegelberger B; Ganser A; Krauter J; Bullinger L; Döhner H; Döhner K
Blood; 2013 Jun; 121(23):4769-77. PubMed ID: 23632886
[TBL] [Abstract][Full Text] [Related]
55. A new prognostic risk model for acute myeloid leukemia patients based on telomere-related genes.
Zhang F; Du H; Hu C; Song Y
Leuk Res; 2023 Dec; 135():107404. PubMed ID: 37844405
[TBL] [Abstract][Full Text] [Related]
56. A novel 4-mRNA signature predicts the overall survival in acute myeloid leukemia.
Chen Z; Song J; Wang W; Bai J; Zhang Y; Shi J; Bai J; Zhou Y
Am J Hematol; 2021 Nov; 96(11):1385-1395. PubMed ID: 34339537
[TBL] [Abstract][Full Text] [Related]
57. TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML.
Mohamed AM; Balsat M; Koering C; Maucort-Boulch D; Boissel N; Payen-Gay L; Cheok M; Mortada H; Auboeuf D; Pinatel C; El-Hamri M; Tigaud I; Hayette S; Dumontet C; Cros E; Flandrin-Gresta P; Nibourel O; Preudhomme C; Thomas X; Nicolini FE; Solly F; Guyotat D; Campos L; Michallet M; Ceraulo A; Mortreux F; Wattel E
Leuk Res; 2017 May; 56():21-28. PubMed ID: 28167452
[TBL] [Abstract][Full Text] [Related]
58. Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.
Döhner K; Thiede C; Jahn N; Panina E; Gambietz A; Larson RA; Prior TW; Marcucci G; Jones D; Krauter J; Heuser M; Voso MT; Ottone T; Nomdedeu JF; Mandrekar SJ; Klisovic RB; Wei AH; Sierra J; Sanz MA; Brandwein JM; de Witte T; Jansen JH; Niederwieser D; Appelbaum FR; Medeiros BC; Tallman MS; Schlenk RF; Ganser A; Serve H; Ehninger G; Amadori S; Gathmann I; Benner A; Pallaud C; Stone RM; Döhner H; Bloomfield CD
Blood; 2020 Jan; 135(5):371-380. PubMed ID: 31826241
[TBL] [Abstract][Full Text] [Related]
59. NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.
Chretien AS; Fauriat C; Orlanducci F; Rey J; Borg GB; Gautherot E; Granjeaud S; Demerle C; Hamel JF; Cerwenka A; von Strandmann EP; Ifrah N; Lacombe C; Cornillet-Lefebvre P; Delaunay J; Toubert A; Arnoulet C; Vey N; Olive D
Oncotarget; 2017 Jul; 8(30):49548-49563. PubMed ID: 28548938
[TBL] [Abstract][Full Text] [Related]
60. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
Palomo L; Garcia O; Arnan M; Xicoy B; Fuster F; Cabezón M; Coll R; Ademà V; Grau J; Jiménez MJ; Pomares H; Marcé S; Mallo M; Millá F; Alonso E; Sureda A; Gallardo D; Feliu E; Ribera JM; Solé F; Zamora L
Oncotarget; 2016 Aug; 7(35):57021-57035. PubMed ID: 27486981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
